Airway Pharmacology and Treatment最新文献_第4页

Airway management of a giant thoracic ganglioneuroma causing airway obstruction in a 3-year-old child 3岁儿童巨大胸神经节神经瘤致气道阻塞的气道处理

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_7_22

Alok Kumar, Simrandeep Singh, N. Tiwari, A. Joshi

引用次数: 0

Redefining exchange of tracheal tube from nasal to oral in high risk sepsis patient 重新定义高危脓毒症患者气管插管由鼻转口

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_13_22

R. Khan, A. Haris, Abdullah Al Jadidi, N. Kaul

引用次数: 0

Awake fibreoptic intubation in an adult with retrognathia: An anaesthetic challenge 清醒纤维插管在成人后颌:麻醉的挑战

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_14_22

Rajnish Kumar, P. Kumari, P. Kandrakonda, Saras Singh

引用次数: 0

Discretion is the better part of valour: Non-operating room anaesthesia for tissue diagnosis of a mediastinal mass 谨慎是勇敢的最好部分:非手术室麻醉对纵隔肿块的组织诊断

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_5_22

Priyanka Karnik, N. Dave, S. Rawlani, Vaibhav Dhabe

引用次数: 0

“Never burn your bridges” – A difficult airway scenario “永远不要自断后路”——一个困难的气道场景

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_25_22

Juhi Sharma, Tushar Mittal

引用次数: 0

An alternate way of fixing endotracheal tube during cleft lip and cleft palate surgery in children 儿童唇腭裂手术中气管插管固定的一种替代方法

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_22_22

S. Nayak, Ankur Khandelwal, B. Das

引用次数: 0

The airway challenge 气道挑战

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_32_22

V. Ramkumar

引用次数: 0

Awake intubation with i-scope videolaryngoscope in a case of limited mouth opening 清醒插管用i-scope视频喉镜在一例有限的张嘴

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_24_22

Sarfaraz Ahmad, S. Naaz, Rajnish Kumar, Neeraj Kumar

引用次数: 0

Perioperative adverse respiratory events in children with obstructive sleep apnoea 阻塞性睡眠呼吸暂停患儿围手术期不良呼吸事件

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_10_22

S. Thampi, S. Chong, D. Pawar

{"title":"Perioperative adverse respiratory events in children with obstructive sleep apnoea","authors":"S. Thampi, S. Chong, D. Pawar","doi":"10.4103/arwy.arwy_10_22","DOIUrl":"https://doi.org/10.4103/arwy.arwy_10_22","url":null,"abstract":"Background: Obstructive sleep apnoea (OSA) in children is associated with the development of perioperative adverse respiratory events. The aim of our study was to find out the incidence of perioperative adverse respiratory events, to identify the risk predictors and to determine the appropriate anaesthetic agents in children with OSA. Methods: After obtaining approval from the the Institutional Review Board, 189 children with OSA who had undergone adenotonsillectomy between 2004 and 2009 were selected from a retrospective review of case files. Variables recorded included demographic data, coexistent medical illnesses, anaesthetic techniques (including induction agents and muscle relaxants) and perioperative analgesia. The severity of OSA was determined based on polysomnographic criteria. Adverse events including difficult airway, desaturation due to bronchospasm or laryngospasm, postoperative desaturation and unplanned intensive care unit (ICU) admission occurring up to 24 h postoperatively were recorded. Results: The incidence of perioperative respiratory adverse events was 19.6%. Severe OSA (odds ratio [OR] 5.8; 95% confidence interval [CI] 1.8–18.53; P = 0.003) and moderate OSA (OR 3.9; 95% CI 1.1–13.1; P = 0.029) were independent risk factors associated with complications. There was no correlation between the intraoperative anaesthetic techniques or use of perioperative opioid analgesics and the perioperative adverse respiratory events. Conclusions: Preoperative diagnosis of OSA using polysomnography has been shown to identify children who are at increased risk of perioperative adverse respiratory events in children. In our review, 19.6% of children with OSA were at risk. The use of a severity index may better identify children at higher risk.","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"22 1","pages":"70 - 76"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77793101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Measuring what matters: Respiratory archetypes in extreme preterm neonates 衡量什么是重要的:极端早产儿的呼吸原型

Airway Pharmacology and Treatment Pub Date : 2022-05-01 DOI: 10.4103/arwy.arwy_11_22

A. Kolisambeevi, Femitha Pournami, A. Prithvi, Anand Nandakumar, Jyothi Prabhakar, Naveen Jain

{"title":"Measuring what matters: Respiratory archetypes in extreme preterm neonates","authors":"A. Kolisambeevi, Femitha Pournami, A. Prithvi, Anand Nandakumar, Jyothi Prabhakar, Naveen Jain","doi":"10.4103/arwy.arwy_11_22","DOIUrl":"https://doi.org/10.4103/arwy.arwy_11_22","url":null,"abstract":"Background: Descriptions of course of illness during prolonged intensive care is as essential as studying outcomes in extremely low gestational age neonates (ELGANs). Understanding the expected trajectory of respiratory illness aids in the recognition of risk factors followed by appropriate counselling and resource allocation. We studied the patterns of respiratory illness in ELGAN over the first 2 weeks and its association with bronchopulmonary dysplasia (BPD). Methodology: Levels of respiratory care in ELGAN from 2017 to 2021 were analysed. They were classified into four groups (pragmatically at the bedside) based on oxygen requirements as Category 1: persistent low needs (PL) – FIO2 <0.3 on day 3, and FIO2 <0.3 at 2 weeks, Category 2: progressive worsening (PW) – FIO2 <0.3 on day 3, worsening to >0.3 at 2 weeks, Category 3: persistent high needs (PH) – FIO2 >0.3 on day 3, continuing to need >0.3 at 2 weeks and Category 4: progressive improvement (PI) – FIO2 >0.3 on day 3, improving to <0.3 at 2 weeks. The proportion of infants in each group who developed BPD was also determined. Results: Seventy-four survivors of 91 live-born ELGAN were included, of whom 29.7% developed BPD. Most infants were in PL category (83.8%). Those in the worse categories (PW and PH) constituted only 4.05%. The association of classification as worse patterns (PW or PH) with BPD was not statistically significant, but the numbers were very small. Conclusions: Major proportion of ELGAN were categorised into reassuring archetypes of respiratory requirements. Drawing conclusions about the association with BPD may need analysis of a larger number of infants.","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"782 1","pages":"65 - 69"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80660578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0